Mesirow Financial Investment Management Inc. Sells 20,186 Shares of CVS Health Co. (NYSE:CVS)

Mesirow Financial Investment Management Inc. reduced its stake in CVS Health Co. (NYSE:CVS - Free Report) by 13.6% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 128,336 shares of the pharmacy operator's stock after selling 20,186 shares during the period. Mesirow Financial Investment Management Inc.'s holdings in CVS Health were worth $8,070,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds have also made changes to their positions in the stock. Garland Capital Management Inc. lifted its holdings in CVS Health by 0.3% in the 2nd quarter. Garland Capital Management Inc. now owns 60,810 shares of the pharmacy operator's stock valued at $3,591,000 after acquiring an additional 160 shares during the last quarter. Sound Income Strategies LLC lifted its stake in CVS Health by 7.2% during the third quarter. Sound Income Strategies LLC now owns 2,397 shares of the pharmacy operator's stock valued at $151,000 after purchasing an additional 162 shares during the last quarter. Plimoth Trust Co. LLC boosted its holdings in CVS Health by 0.4% during the second quarter. Plimoth Trust Co. LLC now owns 46,637 shares of the pharmacy operator's stock worth $2,754,000 after buying an additional 174 shares in the last quarter. Hexagon Capital Partners LLC grew its position in CVS Health by 3.5% in the third quarter. Hexagon Capital Partners LLC now owns 5,268 shares of the pharmacy operator's stock worth $331,000 after buying an additional 178 shares during the last quarter. Finally, Pallas Capital Advisors LLC lifted its position in shares of CVS Health by 2.5% during the 2nd quarter. Pallas Capital Advisors LLC now owns 7,458 shares of the pharmacy operator's stock valued at $447,000 after acquiring an additional 183 shares during the last quarter. 80.66% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

CVS has been the subject of several analyst reports. UBS Group upped their target price on CVS Health from $60.00 to $62.00 and gave the company a "neutral" rating in a report on Thursday. Truist Financial raised their target price on shares of CVS Health from $66.00 to $76.00 and gave the stock a "buy" rating in a report on Friday, October 11th. Deutsche Bank Aktiengesellschaft cut their price target on shares of CVS Health from $64.00 to $63.00 and set a "hold" rating on the stock in a report on Friday, August 9th. Barclays decreased their price objective on shares of CVS Health from $75.00 to $71.00 and set an "overweight" rating for the company in a research note on Thursday. Finally, TD Cowen upgraded CVS Health from a "hold" rating to a "buy" rating and increased their target price for the company from $59.00 to $85.00 in a report on Friday, October 4th. Nine research analysts have rated the stock with a hold rating and twelve have given a buy rating to the company's stock. According to data from MarketBeat, the company currently has an average rating of "Moderate Buy" and an average price target of $73.00.

CVS Health Stock Performance

Shares of CVS stock traded down $1.53 during trading on Friday, reaching $55.54. The company had a trading volume of 13,650,265 shares, compared to its average volume of 13,590,173. The company has a market capitalization of $69.87 billion, a PE ratio of 14.10, a PEG ratio of 0.94 and a beta of 0.55. The company has a debt-to-equity ratio of 0.80, a current ratio of 0.80 and a quick ratio of 0.66. The firm's 50 day simple moving average is $59.56 and its two-hundred day simple moving average is $59.12. CVS Health Co. has a one year low of $52.77 and a one year high of $83.25.

CVS Health (NYSE:CVS - Get Free Report) last posted its quarterly earnings data on Wednesday, November 6th. The pharmacy operator reported $1.09 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.08 by $0.01. The business had revenue of $95.43 billion during the quarter, compared to the consensus estimate of $92.72 billion. CVS Health had a net margin of 1.36% and a return on equity of 10.72%. CVS Health's quarterly revenue was up 6.3% compared to the same quarter last year. During the same period in the prior year, the firm earned $2.21 EPS. Sell-side analysts forecast that CVS Health Co. will post 6.18 earnings per share for the current year.

CVS Health Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, November 1st. Shareholders of record on Monday, October 21st were issued a $0.665 dividend. This represents a $2.66 dividend on an annualized basis and a yield of 4.79%. The ex-dividend date was Monday, October 21st. CVS Health's dividend payout ratio (DPR) is currently 67.51%.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.